FDA Likely To Require Antidepressant “Black Box” For Pediatric Suicidality

FDA will reach an internal decision on a “black box” warning in the next few days. The agency “probably will” go along with a 15-8 advisory committee vote in favor of the labeling change, ODE I Acting Director Temple tells House subcommittee.